CAS 1429755-57-6

Nom du produit:(E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide

IUPAC Name:1-{3-cyano-4-[(E)-[(dimethylamino)methylidene]amino]phenyl}-3-(1-hydroxy-2-methylpropan-2-yl)thiourea

Unité d'emballage	Stock disponible	Prix($)
CM329512-250g	in stock	ǊȎưǯ
CM329512-500g	in stock	ĽŢŉƞ
CM329512-1000g	in stock	ưƄǊŢ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1429755-57-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1429755-57-6; Formule moléculaire:C15H21N5OS; Point de fusion:-; Code SMILES:CN(C)/C=N/C1=CC=C(NC(NC(C)(C)CO)=S)C=C1C#N; Densité:

: Numéro de catalogue:CM329512; Poids moléculaire:319.43; Point d'ébullition:; N° Mdl:; Stockage:Keep in a tight container and store at abient temperature

: Tucatinib; In August 2023, phase III results for tyrosine kinase inhibitor Tukysa (tucatinib), in combination with antibody-drug conjugate Kadcyla (ado-trastuzumab emtansine), which met its primary endpoint of progression-free survival in HER-2 breast cancer patients.
TUKYSA (tucatinib) is an oral medicine that is a tyrosine kinase inhibitor of the HER2 protein. It is approved in more than 40 countries.